ミネソタ州における膵臓がんの臨床試験
ミネソタ州内の拠点で、膵臓がんに関する35件の研究が参加者を募集しています。
ミネソタ州内の都市
公式研究テキスト（英語）
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07226856A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Health Partners Frauenshuh Cancer Center, Saint Louis Park
- Health Partners Cancer Center at Regions Hospital, Saint Paul
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Mayo Clinic Cancer Center, Rochester
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Allina Health Cancer Institute - Hematology Cancer Care Services, Minneapolis
- HealthPartners Frauenshuh Cancer Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US066, Maple Grove
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/21更新 · NCT06271291A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- Mayo Clinic Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07450859A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0129, Rochester
- Local Institution - 0174, Rochester
- Local Institution - 0181, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680CREO - Microwave Ablation Feasibility Study
- Mayo Clinic Rochester, Rochester
被験者募集中
18歳以上 · 全性別 · 2026/09/14更新 · NCT07817147Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/14更新 · NCT04858009Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- University of Minnesota/Masonic Children's Hospital, Minneapolis
被験者募集中観察研究
17歳以下 · 全性別 · 2026/09/11更新 · NCT06651580Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Sanford Joe Lueken Cancer Center, Bemidji
- Mayo Clinic in Rochester, Rochester
- Sanford Thief River Falls Medical Center, Thief River Falls
- 他1件
被験者募集中観察研究
50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- Mayo Clinical Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07644559The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Mayo Clinic, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05245500Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Sanford Joe Lueken Cancer Center, Bemidji
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/10更新 · NCT05518903Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- 他2件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- M Health Fairview University of Minnesota Medical Center - East Bank /ID# 276200, Minneapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT05005403A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Mayo Clinic Rochester, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- 他17件
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940Axelopran for Advanced Cancer in Patients Receiving Opioids
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/05更新 · NCT07354919A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/03/10更新 · NCT06151223Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/09更新 · NCT00830557A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Minneapolis
- Ohio State University Telemedicine, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
- University of Minnesota/Masonic Cancer Center, Minneapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/03更新 · NCT06411795cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Allina Health Cancer Institute, Minneapolis
- Mayo Clinic, Rochester
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/01/16更新 · NCT06973564LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Minnesota Oncology - Burnsville, Burnsville
- Mercy Hospital, Coon Rapids
- Fairview Southdale Hospital, Edina
- 他18件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duluth
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- Exelixis Clinical Site #14, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/05更新 · NCT05932862ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。